Rosetta Genomics Announces Issuance of Additional U.S. Patent

Wednesday, May 11, 2011 General News
Email Print This Page Comment
Font : A-A+

Strengthens its Broad and Deep microRNA Intellectual Property for microRNA-based Diagnostics

Company Contact:

Investor Contacts:

Rosetta Genomics

Lippert/Heilshorn & Associates

Ken Berlin, President & CEO

Anne Marie Fields

(215) 382-9000 ext. 326

(212) 838-3777

investors@rosettagenomics.com

afields@lhai.com

or

Bruce Voss

(310) 691-7100

bvoss@lhai.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook